Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: the name of the cancer does not explain the location of the cancer.

Al_bundy_400_profile
Rank: [?]
Vice President
Points: [?]
1181
Rating: [?]
Votes: 15 Score: 3.6
  • Currently 3.6/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

the name of the cancer does not explain the location of the cancer.

posted on Mar 22, 09 09:29AM


I just want to answer one question at a time. These are two very different questions.

1. The first is DO I HAVE CANCER OR NOT?

RECAF CAN ANSWER THIS ONE BETTER THAN ANY OTHER TEST ON THE MARKET!

2. IF I DO...WHERE IS IT?

NO MARKER CURRENTLY ON THE MARKET CAN PINPOINT WHERE THE CANCER IS!

RECAF HOWEVER HAS THE ABILITY TO DO SO! IMAGING!



If scientists could somehow stop the spreading of the cancer cells to other organs, it would save lives. In a new study, scientists think that they have found a gene that is critical for this ability in breast cancer cells.
The more lymph nodes that have breast cancer, the more likely it is that the cancer may be found in other organs as well. This is important to know because it could affect your treatment plan.
Prostate cancers that are resistant to androgen deprivation therapy are more invasive and more likely to spread to other organs than androgen dependent prostate cancers, UCLA cancer researchers have found.
Stomach cancer can be very difficult to diagnose, since its symptoms are common to other ailments. By the time it is discovered that a person has cancer, the cancer has most likely metastasized to other areas of the body, giving the patient a very poor outlook for treatment and survival.

New Message

Please login to post a reply

AGORACOM Quick Tips

Looking for a New Junior Zinc Explorer? ... Learn More!

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote